Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes

Acta Histochemica

Volumn 98, Issue 2, 1996, Pages 229-241

  Augstein, Petra ^a   Schlosser, Michael ^a   Ziegler, Brigitte ^a   Hahmann, Jens ^a   Mauch, Ludwig ^b   Ziegler, Manfred ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ELIAS   (Germany)

Author keywords

65 kD isoform; cytoplasmic islet cell antibodies; diabetes mellitus; Dot blot; ELISA; epitope; glutamic acid decarboxylase; islet cells; monoclonal antibodies; pancreas

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PANCREAS ISLET CELL;

EID: 0029982458     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0065-1281(96)80042-0     Document Type: Article

References (39)

1. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, and Maclaren NK (1993) Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91: 350-356
2. Augstein P, Braun B, Ziegler B, Woltanski K-P, and Ziegler, M (1992) Characterization of two porcine pro-insulin reactive monoclonal antibodies by immunostaining of β-cells in pancreatic sections of different species. Acta histochem 93: 433-440
3. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, and Lernmark A (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (Lond) 298: 167-169
4. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz M, Solimena M, Cascalho F, Folli F, Richter-Olsen H, and De Camilli P (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
5. Björk E, Velloso LA, Kämpe O, and Karlsson AF (1994) GAD autoantibodies in IDDM, Stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43: 161-165
6. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, and Bottazzo GF (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149
7. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, and Bosi E (1995) Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38: 816-822
8. Bosi E, and Bonifacio E (1994) Autoantibodies in insulin-dependent diabetes mellitus. J Endocrinol Invest 17: 521-531
9. Bottazzo GF, Florin-Christensen A, and Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279-1283
10. Bottazzo GF, and Doniach D (1978) Islet cell antibodies (ICA) in diabetes mellitus: evidence of an auto-antigen common to all the cells in the islet of Langerhans. Ric Clin Lab 8: 29-38
11. Butler MH, Solimena M, Dirkx R, Haysay A, and De Camilli P (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in Stiff-man syndrome. J Exp Med 178: 2097-2106
12. Chaillous L, Delamaire M, Elmansour A, Maugendre D, Rohmer V, Joseph MG, Lecompte P, Limal JM, Charbonnel B, Allannic H, and Sai P (1994) Combined analysis of islet cell antibodies which crossreact with mouse pancreas, antibodies to the Mr 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM. Diabetologia 37: 491-499
13. Dotta F, Anastasi E, Tiberti C, and Di Mario U (1994) Autoantigens in type 1 diabetes mellitus. J Endocrinol Invest 17: 497-508
14. Genovese S, Bonifacio E, McNally J, Dean BM, Wagner R, Bosi E, Gale EAM, and Bottazzo GF (1992) Distinct cytoplasmic islet cell antibodies with different risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388
15. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldener JS, Ehrlich H, Awdeh Z, Alper CA, Jackson RA, and Eisenbarth GS (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 41: 347-353
16. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Peterson JS, Boel E, Dyrberg T, and Lernmark A (1993) Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64 K autoantibodies positivity at onset predict diabetes type. J Clin Invest 91: 368-374
17. Kawasaki E, Takino H, Yano M, Kotani S, Matsumoto K, Takno Y, Yamaguchi Y, Akazawa S, and Nagataki S (1974) Autoantibodies to glutamic acid decarboxylase in patients with IDDM and auto-immune thyroid disease. Diabetes 43: 80-86
18. Kim J, Richter W, Aanstoot HJ, Shi Y, Rajotte R, Warnock G, and Baekkeskov S (1993) Differential expression of GAD65 and GAD67 in human, rat and mouse pancreatic islets. Diabetes 42: 1799-1808
19. Lendrum R, Walker G, and Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1: 880-882
20. Lühder F, Schlosser M, Mauch L, Haubruck M, Rjasanowski I, Michaelis D, Kohnert K-D, and Ziegler M (1994) Autoantibodies against GAD65 rather than GAD67 predict the onset of Type 1 diabetes. Autoimmunity 19: 71-80
21. Lühder F, Woltanski KP, Hamann J, Klöting I, Ziegler B, and Ziegler M (1992) Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by Western blotting and immunotrapping enzyme activity assay. Diab Res 20: 97-107
22. Mauch L, Abney CC, Berg H, Scherbaum WA, Liedvogel B, and Northemann W (1993) Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus. Eur J Biochem 212: 597-603
23. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, and Eisenbarth GS (1985) 'Cytoplasmic' islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate. Diabetes 34: 617-619
24. Petersen JS, Dyrberg T, Karlsen A, Karlsen AE, Molvig J, Michelsen B, Nerup J, Mandrup-Poulsen T, and the CERCTG (1994) Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of β-cell function and remission in recent-oncet IDDM after cyclosporin treatment. Diabetes 43: 1291-1296
25. Richter W, Eiermann TH, Endl J, Seissler J, Wohlfahrt S, Brandt M, Jungfer M, and Scherbaum WA (1993a) Human monoclonal islet cell specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 36: 785-790
26. Richter W, Seissler J, Northemann W, Wohlfahrt S, Meinck HM, and Scherbaum WA (1993b) Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in Stiff man syndrome. Diabetes 42: 1642-1648
27. Sai P, Elmansour A, Audrain M, Charbonnel B, and Bardet S (1993) Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: A follow-up study in Type 1 (insulin-dependent) diabetic patients and in first degree relatives. Diabetologia 36: 778-784
28. Schlosser M, Hahmann J, Ziegler B, and Ziegler M (1995) Sensitiver Sandwich-ELISA zur quantitativen Bestimmung von Glutamatdekarboxylase (GAD65) in pankreatischen Inseln und Organextrakten. Diabetes und Stoffwechsel 4: 204A
29. Schlosser M, Witt S, Ziegler B, and Ziegler M (1991) Influence of target cell preparation on binding of monoclonal islet cell reactive antibodies (mc-ICRA) in cellular enzyme-linked immunosorbent assay (CELISA). J Immunol Meth 140: 101-109
30. Solimena M, Butler MH, and De Camilli P (1994) GAD, diabetes, and Stiff-Man syndrome: Some progress and more questions. J Endocrinol Invest 17: 509-520
31. Solimena M, and De Camilli P (1991) Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-man syndrome und insulin-dependent diabetes mellitus. Trends Neurosci 14: 452-457
32. Tarn AC, Dean BM, Schwarz G, Thomas JM, Ingram D, Bottazzo GF, and Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet 85: 845-849
33. Thai A-C, and Eisenbarth GS (1993) Natural history of IDDM. Diab Rev 1: 1-14
34. Timsit J, Caillat-Zucman S, Blondel H, Chedin P, Bach JF, and Boitard C (1992) Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 792-795
35. Tuomi T, Rowley MJ, Knowles WJ, Chen Q-Y, McAnally T, Zimmet PZ, and Mackay IR (1994) Auto-antigenic properties of native and denaturated glutamic acid decarboxylase: evidence for a conformational epitope. Clin Immunol and Immunopath 71: 53-59
36. Ujihara N, Kendra D, Gianani R, Boel E, Liping Y, and Powers AC (1994) Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 43: 968-975
37. Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, and Karlsson EA (1993) Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 91: 2084-2090
38. Ziegler B, Augstein P, Lühder F, Northemann W, Hamann J, Schlosser M, Kloting I, and Ziegler M (1994) Monoclonal antibodies specific to glutamic acid decarboxylase 65 kDa isoform derived from non-obese diabetic (NOD) mouse. Diab Res 25: 47-64
39. Ziegler B, Augstein P, Schröder D, Mauch L, Hahmann J, Schlosser M, and Ziegler M (1996) Glutamate decarboxylase (GAD) is not detectable on the surface of rat islet cells examined by cytofluorometry and complement-dependent antibody-mediated cytotoxicity of monoclonal GAD antibodies. Horm Metab Res 28: 11-15